Owlet initiated with a Buy at Lucid Capital

Lucid Capital initiated coverage of Owlet (OWLT) with a Buy rating and $15 price target The company’s $300 Dream Sock is a best-selling baby smart monitor on Amazon and the only FDA-cleared over-the-counter medical-grade pulse oximeter for infants, the analyst tells investors in a research note. The firm says Owlet “has all the ingredients to become a large and very profitable company.”